Should Investors - and their hired hands in the Fund Management/Private Banking Industry - really care if Oligopolies and Monopolies are not held in check? Higher profits at the cost of higher inequality may be attractive in a Darwinian world but how does this fit in with the current focus on ESG, SRI and Impact Investing?
(9-Jan-2019)
Why the Regulators went soft on Monopolies
On October 1, the Delaware Court of Chancery denied a motion to dismiss a
Caremark claim in In re Clovis Oncology, Inc. Derivative Litigation.
Under In re ...
1 hour ago
0 comments:
Post a Comment